A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
Clinical trial NCT06725758 · RECRUITING
Trial details
- NCT number
- NCT06725758
- Sponsor
- Orion Corporation, Orion Pharma
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-26
- Primary completion
- 2027-12-31
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.